Clinical Trial

Enhancement of the Haemostatic Effect of Platelets in the Presence of High Normal Concentrations of Von Willebrand Factor

Study acronym: Will-Plate
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Assessment of high-normal dosage of Wilate ® compared to placebo administered in combination with platelets to assess reduction of amount of blood loss, need of transfusion products and outcome (length of stay, mortality) in patients with bleeding in comparison.
Trial Details
NCT Number NCT04555785
Lead Sponsor University Hospital, Basel, Switzerland
Conditions Bleeding
Enrollment 120 participants
Start Date 2022-04-01
Primary Completion 2027-11 (estimated)
Study Completion 2028-11 (estimated)
Updated on ClinicalTrials.gov 2026-06-11